Clinical Trial Detail

NCT ID NCT04273061
Title Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity (CAPTIV-8)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors British Columbia Cancer Agency
Indications

lung cancer

breast cancer

urinary system cancer

sarcoma

Advanced Solid Tumor

female reproductive organ cancer

hepatobiliary system cancer

male reproductive organ cancer

gastrointestinal system cancer

pancreatic cancer

Therapies

Atezolizumab

Age Groups: adult senior

No variant requirements are available.